René Geci is a Systems Biologist who recently finished his master’s degree and now joins us as our first PhD student in collaboration with the RWTH Aachen (Germany) under…..

Alicia will lead research programs on developing and applying physiologically based kinetic (PBK) models and developing strategies for new approach methodologies for chemical risk assessment…..

2021 was a busy year for the esqLABS software team, with lot of effort invested to deliver the new version 10 of the open-source modeling software “Open-Systems-Pharmacology Suite” (OSPSuite), …

In 2021, for our fourth year, esqLABS has again grown in numbers. After doubling our size in 2020, we were again able to grow our the esqLABS family by …

esqLABS has had the privilege to provide a detailed 3-day training to 15 Scientists from the U.S. Food and Drug Administration Division of Pharmacometrics, Office of Clinical Pharmacology …

Dr. Huan Yang is a mathematical modeler, who is passionate about computational modeling, data analysis, and machine learning for life-science innovation. Before joining esqLABS, Huan has applied systems modeling…

esqLABS is partnering with 17 institutions across the EU and the US to further develop computational approaches for next-generation risk assessment (NGRA) to provide a solution for advancing human risk assessment of chemicals without the use of animals…

Walter Schmitt is an M&S scientist with more than 25 years of experience in the pharmaceutical and crop science industries. He will strengthen the esqLABS team of scientists with his deep knowledge in mechanistic and physiologically based modeling …

Dr. Huan Yang is a mathematical modeler, who is passionate about computational modeling, data analysis, and machine learning for life-science innovation. Before joining esqLABS, Huan has applied systems modeling…

We are seeking a highly talented and motivated Senior Scientist PBTK and QST (m/f/d), keen on driving innovation and setting new boundaries in systems toxicology …

We are seeking a highly talented and motivated PhD Student QST (qAOP) (m/f/d), keen on driving innovation and setting new boundaries in systems toxicology …

While the world seemed to stay still, this year was full of (e)motions for the Open Systems Pharmacology Community. esqLABS is thrilled to contribute to this initiative and witness its continued success …

What a year 2020! The esqLABS team has more than doubled in size and continues to grow: we now employ 8 great personalities from around the globe …

Dr. Frederico Martins is pharmacist with a PhD in Pharmaceutical Sciences from the University of São Paulo, Brazil. Prior to joining esqLABS, Dr. Martins worked as a pharmacometrics leader at Galapagos Pharmaceuticals in Paris …

Christian Maass is a physicist and computational biologist with over eight years of academic and industrial experience, where he established a strong national and international network. He is passionate about the integration …

Georgios Daskalakis is an experienced Software Developer with over 4 years of customer centric experience in software development in various fields. He started programming for BTC AG, contributing to the further …

We are seeking a highly talented and motivated Scientific Director PBPK (m/f), keen on driving innovation and setting new boundaries in systems pharmacology …

From within the „MoDiPro“ collaborations network, esqLABS & Partners have submitted a grant application for the GlucoSys Project. GlucoSys aims at developing a new technology solution for the control of blood glucose of intensive care patients in ICU wards…

esqLABS is partnering with the Saarland University and the Bayer AG for the public-funding project OSMOSES to further develop the OPEN SOURCE software Open Systems Pharmacology Suite. The overall aim of the OSMOSES project is the further development of the “Open Systems…

esqLABS GmbH is founded as a German Limited Liability Company and registered with the register of commerce in Oldenburg, Germany.